CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European Neuropsychopharmacology

• Publication date

  2015-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.euroneuro.2015.04.023PMID 26024928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis

  2015cited by this paper
• Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.

  2015cited by this paper
• CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment.

  2014cited by this paper
• Neuronal and Glia-Related Biomarkers in Cerebrospinal Fluid of Patients with Acute Ischemic Stroke

  2014cited by this paper
• Bipolar disorder diagnosis: challenges and future directions.

  2013cited by this paper
• Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta‐analysis

  2013cited by this paper
• The societal cost of bipolar disorder in Sweden

  2013cited by this paper
• Cerebrospinal Fluid Biomarkers Mirror Rate of Cognitive Decline

  2013cited by this paper
• The microglial activation state regulates migration and roles of matrix-dissolving enzymes for invasion

  2013cited by this paper
• Altered Concentrations of Amyloid Precursor Protein Metabolites in the Cerebrospinal Fluid of Patients with Bipolar Disorder

  2013cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Neurocognitive function in bipolar disorder: a comparison between bipolar I and II disorder and matched controls

  2012influential reference
• Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study

  2012cited by this paper
• Biomarkers for Microglial Activation in Alzheimer's Disease

  2011cited by this paper
• Amyloid-β42 is Associated with Cognitive Impairment in Healthy Elderly and Subjective Cognitive Impairment

  2011cited by this paper
• Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative.

  2011cited by this paper
• Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease

  2011cited by this paper
• The impact of neurocognitive impairment on occupational recovery of clinically stable patients with bipolar disorder: a prospective study

  2011cited by this paper
• Serum inflammatory proteins and frontal lobe dysfunction in patients with cardiovascular risk factors

  2010cited by this paper
• The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.

  2010cited by this paper
• eview athways underlying neuroprogression in bipolar disorder : Focus on nflammation , oxidative stress and neurotrophic factors

  2010cited by this paper
• YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease.

  2010influential reference
• Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients

  2010influential reference
• Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.

  2010cited by this paper
• Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives.

  2009cited by this paper
• Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis.

  2009influential reference
• A history of childhood attention‐deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD

  2009cited by this paper
• Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature.

  2009cited by this paper
• Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.

  2008cited by this paper
• High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania.

  2007cited by this paper
• Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence.

  2006cited by this paper
• A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder.

  2006cited by this paper
• The significance of neuroinflammation in understanding Alzheimer’s disease

  2006cited by this paper
• Physiological Levels of Pro- and Anti-Inflammatory Mediators in Cerebrospinal Fluid and Plasma: A Normative Study

  2005cited by this paper
• The development of alcohol use disorders.

  2005cited by this paper
• Inflammatory Cytokines Induce Production of CHI3L1 by Articular Chondrocytes*

  2005cited by this paper
• Neuropsychological dysfunction in bipolar affective disorder: a critical opinion.

  2005cited by this paper
• Evaluation of the Drug Use Disorders Identification Test (DUDIT) in Criminal Justice and Detoxification Settings and in a Swedish Population Sample

  2004cited by this paper
• Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).

  2003influential reference
• Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases.

  2003cited by this paper
• Health care utilization and costs among privately insured patients with bipolar I disorder.

  2002cited by this paper
• YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Purulent Meningitis

  2002cited by this paper
• Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity.

  1999cited by this paper
• The mini international neuropsychiatric interview

  1998cited by this paper
• The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

  1998cited by this paper
• Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages.

  1998cited by this paper
• Estimating Mediated Effects in Prevention Studies

  1993cited by this paper
• Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.

  1993cited by this paper

• Integrative transcriptomic meta-analysis reveals immune, synaptic, and non-coding RNA dysregulation in bipolar disorder across brain and blood.

  2026cites this paper
• SuPAR levels are increased in sera of euthymic patients with bipolar disorder and correlate with executive functions and memory.

  2026cites this paper
• Association Between Inflammatory Markers and Cognitive Function in Adults With Bipolar Disorder: A Systematic Review.

  2025cites this paper
• Association between neutrophil-to-lymphocyte ratio and bipolar disorder: A systematic review and meta-analysis

  2025cites this paper
• Neuroimmunometabolism: How Metabolism Orchestrates Immune Response in Healthy and Diseased Brain.

  2025cites this paper
• Patients With Older-Age Bipolar Disorder (OABD) Visiting a Memory Clinic: Differentiating Underlying Pathophysiology With MRI and Cerebrospinal Fluid Markers.

  2025cites this paper
• The St. Göran Project: A Multipronged Strategy for Longitudinal Studies for Bipolar Disorders

  2025cites this paper
• The Neglected Sibling: NLRP2 Inflammasome in the Nervous System

  2024cites this paper
• Neurophysiological profiles of patients with bipolar disorders as probed with transcranial magnetic stimulation: A systematic review

  2024cites this paper
• Nuclear GAPDH in cortical microglia mediates cellular stress-induced cognitive inflexibility

  2024cites this paper
• Cognitive and inflammatory heterogeneity in severe mental illness: Translating findings from blood to brain

  2023cites this paper
• The correlation between the severity of cerebral microbleeds and serum HMGB1 levels and cognitive impairment in patients with cerebral small vessel disease

  2023cites this paper
• Neuroprogression in bipolar disorder

  2022cites this paper
• Nuclear GAPDH in cortical microglia mediates stress-induced cognitive inflexibility

  2022cites this paper
• Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress–Induced Damage in Patients with Bipolar Disorder

  2022cites this paper
• Robust Structural Color Beads by Self-Adhesion Amorphous Colloidal Particles for Detection of Cerebrospinal Fluid Biomarkers

  2022cites this paper
• Blood-brain barrier’s interplay with peripheral and central inflammation as a pathophysiological mechanism of bipolar disorders

  2021cites this paper
• Peripheral inflammatory markers associated with brain-volume reduction in patients with bipolar I disorder.

  2021cites this paper
• Are Mannan-binding Lectine Serin Protease-2 and Alphα-1-microglobulin and Bukinin Precursor the Potential Biomarkers of Manic Episode? A Study via Urinary Proetomic Analysis

  2021cites this paper
• Immune mechanisms in bipolar disorder: Evidence and implications

  2021cites this paper
• Add-on memantine may improve cognitive functions and attenuate inflammation in middle- to old-aged bipolar II disorder patients.

  2020cites this paper
• Inflammation, brain structure and cognition interrelations among individuals with differential risks for bipolar disorder.

  2020cites this paper
• Overlapping mechanisms linking insulin resistance with cognition and neuroprogression in bipolar disorder.

  2020cites this paper
• Sex difference in glia gene expression in the dorsolateral prefrontal cortex in bipolar disorder: Relation to psychotic features.

  2020cites this paper
• Bipolar Disorder

  2020cites this paper
• Plasma MCP-1 levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment.

  2020cites this paper
• Inflammation as a Mechanism of Bipolar Disorder Neuroprogression.

  2020cites this paper
• Incidence of Parkinson’s disease, dementia, cerebrovascular disease and stroke in bipolar disorder compared to other psychiatric disorders: An electronic health records network study of 66 million people

  2020cites this paper
• Influence of genetic variations in IL1B on brain region volumes in bipolar patients and controls.

  2020cites this paper
• Distinct Associations of Cognitive Impairments and Reduced Gray Matter Volumes in Remitted Patients with Schizophrenia and Bipolar Disorder

  2020cites this paper
• Chitinase-3-like protein 1 levels in bipolar disorder

  2019cites this paper
• Neuroinflammation and cognition across psychiatric conditions

  2019cites this paper
• On Neuroimmunology and Brain Function: Experimental and Clinical Studies

  2019cites this paper
• Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be?

  2019cites this paper
• Cognitive impact in bipolar disorder

  2019cites this paper
• An association between YKL‐40 and type 2 diabetes in psychotic disorders

  2018cites this paper
• The relationship between neutrophil-lymphocyte, platelet–lymphocyte ratio and cognitive functions in bipolar disorder

  2018cites this paper
• Immune-based strategies for mood disorders: facts and challenges

  2018cites this paper
• Assessment of Complement Cascade Components in Patients With Bipolar Disorder

  2018cites this paper
• Biomarkers in cerebrospinal fluid of patients with bipolar disorder versus healthy individuals: A systematic review.

  2018cites this paper
• Early onset of inflammation during ontogeny of bipolar disorder: the NLRP2 inflammasome gene distinctly differentiates between patients and healthy controls in the transition between iPS cell and neural stem cell stages

  2017cites this paper
• Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders

  2017cites this paper
• Multidimensional cognitive impairment in unipolar and bipolar depression and the moderator effect of adverse childhood experiences

  2017cites this paper
• YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s Disease

  2017cites this paper
• Novel Neuroprotective Effect Of Therapeutic Lithium Carbonate Doses In Rat Brain Tissue During Different Treatment Intervals

  2017cites this paper
• Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes.

  2017cites this paper
• A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients.

  2017cites this paper
• [The Relationship of Interleukin-18 and Interleukin-6 Levels with Cognitive Functions in Bipolar Disorder].

  2017cites this paper
• A pilot, open‐label, 8‐week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression

  2017cites this paper
• Putative biological predictors of treatment response in bipolar disorders

  2017cites this paper
• Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder

  2017cites this paper
• The Behavioural and Neural Correlates of Social Cognition: A Dimensional Approach in Youth with Mental Illness

  2017cites this paper
• Medical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems.

  2017cites this paper
• Over-expression of TSPO in the hippocampal CA1 area alleviates cognitive dysfunction caused by lipopolysaccharide in mice.

  2016cites this paper
• Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder

  2016cites this paper
• Exploring the Role of Inflammatory Cytokines in the Pathophysiology, Cognitive Dysfunction and Treatment of Bipolar Disorder: Integrative Evidence Provided by a Proof-of-Concept Study with Adjunctive Minocycline

  2016cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE MEDICINA PROGRAMA DE PÓS-GRADUAÇÃO EM PSIQUIATRIA E CIÊNCIAS DO COMPORTAMENTO

  2016cites this paper
• Polarização M1 e M2 da linhagem U-937 de macrófagos em meio de soro de pacientes com transtorno bipolar

  2016cites this paper
• The role of macrophage polarization on bipolar disorder: Identifying new therapeutic targets

  2016cites this paper
• Mean platelet volume in bipolar disorder: the search for an ideal biomarker

  2016cites this paper
• Bipolar Disorder: The Role of the Kynurenine and Melatonergic Pathways.

  2016cites this paper
• Bipolar Bozuklukta İnterlökin-18 ve İnterlökin-6 Sitokin Seviyelerinin Bilişsel İşlevler ile İlişkisi 2

  2016cites this paper
• Mast cell activation disease and the modern epidemic of chronic inflammatory disease.

  2016cites this paper
• Neuroinflammation in bipolar disorders

  2015cites this paper
• Efficiency of Neuropsychological Methods in Enhancing the Comprehension of Students Suffered from Developmental Dyslexia

  2015cites this paper
• Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications.

  2015cites this paper
• Molecular pathology of suicide

  year unknowncites this paper